Abstract

Objective To determine the efficacy of mlnocycline on reducing reactive hyperplasia in rat models of communicating hydrocephalus.Methods Thirty adult SD rats were randomly divided into hydrocephalic model group (n=10),minocycline-treated hydrocephalic group (n=10) and sham-operated group (n=10); rats in the first two groups were induced communicating hydrocephalus with kaolin intraventricular injections; minocycline (45 mg/kg/day) was administered to hydrocephalic rats one week after the operation; rats in the sham-operated group and hydrocephalic model group were injected with saline.The ventricular dilatation were examined by MRI and Evan' s indexes was calculated two weeks after treatment; glial fibrillary acidic protein (GFAP) and allograft inflammatory factor (AIF-1) expressions were detected by RT-PCR; GFAP and ionized calcium-binding adaptor molecule (Iba-1) were detected by immunohistochemistry and Western blotting.Results Significant difference was noted on ventricular dilatation,Evan's index,and GFAP and AIF-1 expressions among the three groups (P<0.05); the ventricular dilatation,Evan's index,and GFAP and AIF-1 mRNA expressions increased accordingly in the sham-operated group,minocycline-treated hydrocephalic group and hydrocephalic model group (P<0.05).Astrocytes and microglias in the sham-operated group were under dormant state; astrocytes and microglias in the model group were under hyperresponsiveness,while astrocytes and microglias in the minocycline-treated hydrocephalic group showed slight hyperplasia.The expressions of GFAP and Iba-1 in the model group were significantly higher as compared with those in the minocycline-treated hydrocephalic group (P<0.05).Conclusion Minocycline treatment is effective in delaying the development of hydrocephalus with prospective to be the auxiliary therapeutic method of hydrocephalus. Key words: Hydrocephalus; Minocycline; Gliosis

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.